Moreover, a clinical trial reported that the administration of GTE (mainly EGCG) reduced the expression of DNA methyltransferase (DNMT1) and NF-κB mRNA in human rectal tissue, indicating a regulatory role for EGCG in CRC tumorigenesis-related biomarkers [83]. The gene discussed is NFKB1; the disease is colorectal carcinoma.